# Efinopegdutide in type 2 diabetes and obesity: weight loss

Source: https://pepvault.app/research/efinopegdutide-di-prospero-2021

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Efinopegdutide](https://pepvault.app/research#efinopegdutide)

Randomized trial · people

# Efinopegdutide: up to 7.2% more weight loss than placebo at 12 weeks

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In people with type 2 diabetes and severe obesity, efinopegdutide lowered weight in a dose-linked way over 12 weeks, but it did not improve blood sugar control and caused more nausea and vomiting than placebo.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 195
- **Published:** 2021
- **Journal:** Clin Obes

## What they tested

This phase 2 study compared three doses of efinopegdutide with placebo to see how much weight people with type 2 diabetes and class II/III obesity lost over 12 weeks, and how safe the drug was.

## How the study was done

A phase 2, randomized, double-blind, placebo-controlled trial in 195 dosed people with type 2 diabetes (HbA1c, a long-term average of blood sugar, of 6.5%-9.5%) and a body mass index of 35 to 50 kg/m2. They were split evenly into placebo (a dummy treatment) or a 5.0 mg, 7.4 mg or 10.0 mg arm, and the main measure was percent change in body weight at week 12.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking efinopegdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

After removing the placebo effect, body weight fell by 4.6% in the 5.0 mg arm, 5.9% in the 7.4 mg arm and 7.2% in the 10.0 mg arm at week 12, with bigger doses giving more weight loss. HbA1c did not change at any dose, fasting insulin rose slightly, and fasting blood sugar went up in the 5.0 mg and 7.4 mg arms. Side effects, mainly nausea and vomiting, were more common than on placebo, and 144 of 195 people (73.8%) finished treatment.

## What it doesn’t show

This was a short 12-week dose-finding trial, so it does not show whether the weight loss lasts or what happens over longer use. About a quarter of participants did not complete treatment.

## The paper

Di Prospero et al. Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with type 2 diabetes mellitus and obesity: A randomized dose-ranging study. Clin Obes. 2021.

- [PubMed (PMID 33475251)](https://pubmed.ncbi.nlm.nih.gov/33475251/)
- [The paper (DOI 10.1111/cob.12433)](https://doi.org/10.1111/cob.12433)

## The compound

- [Efinopegdutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/efinopegdutide)
- [Efinopegdutide dose guide](https://pepvault.app/lab/dosage/efinopegdutide)

## With this study

### Efinopegdutide

- [Efinopegdutide: the full reference](https://pepvault.app/peptides/efinopegdutide)
- [Efinopegdutide dose guide](https://pepvault.app/lab/dosage/efinopegdutide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/efinopegdutide-10mg)

### Studies

- [Efinopegdutide: MASH resolved in up to 63% vs 13% on placebo](https://pepvault.app/research/efinopegdutide-lawitz-2026)
- [Efinopegdutide: 72.7% liver fat drop vs 42.3% on semaglutide](https://pepvault.app/research/efinopegdutide-romero-gomez-2023)
- [All 3 studies](https://pepvault.app/research#efinopegdutide)

### Compared with

- [Semaglutide vs Efinopegdutide](https://pepvault.app/peptides/compare/semaglutide-vs-efinopegdutide)
- [Survodutide vs Efinopegdutide](https://pepvault.app/peptides/compare/survodutide-vs-efinopegdutide)
- [Pemvidutide vs Efinopegdutide](https://pepvault.app/peptides/compare/pemvidutide-vs-efinopegdutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

## More studies on Efinopegdutide

- [Efinopegdutide: MASH resolved in up to 63% vs 13% on placebo](https://pepvault.app/research/efinopegdutide-lawitz-2026) Randomized trial · people · 2026
- [Efinopegdutide: 72.7% liver fat drop vs 42.3% on semaglutide](https://pepvault.app/research/efinopegdutide-romero-gomez-2023) Randomized trial · people · 2023
- [Every study on Efinopegdutide](https://pepvault.app/research#efinopegdutide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking efinopegdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking efinopegdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Efinopegdutide

- [Efinopegdutide: the full reference](https://pepvault.app/peptides/efinopegdutide)
- [Efinopegdutide dose guide](https://pepvault.app/lab/dosage/efinopegdutide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/efinopegdutide-10mg)

### Studies

- [Efinopegdutide: MASH resolved in up to 63% vs 13% on placebo](https://pepvault.app/research/efinopegdutide-lawitz-2026)
- [Efinopegdutide: 72.7% liver fat drop vs 42.3% on semaglutide](https://pepvault.app/research/efinopegdutide-romero-gomez-2023)
- [All 3 studies](https://pepvault.app/research#efinopegdutide)

### Compared with

- [Semaglutide vs Efinopegdutide](https://pepvault.app/peptides/compare/semaglutide-vs-efinopegdutide)
- [Survodutide vs Efinopegdutide](https://pepvault.app/peptides/compare/survodutide-vs-efinopegdutide)
- [Pemvidutide vs Efinopegdutide](https://pepvault.app/peptides/compare/pemvidutide-vs-efinopegdutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

<!--promo-->

PepVault for iPhone

## Taking efinopegdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Efinopegdutide](https://pepvault.app/research#efinopegdutide)

## The library

- [Efinopegdutide](https://pepvault.app/peptides/efinopegdutide)
- [Efinopegdutide dose guide](https://pepvault.app/lab/dosage/efinopegdutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
